🇺🇸 FDA
Patent

US 8703826

Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

granted A61PA61P11/00A61P11/06

Quick answer

US patent 8703826 (Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P11/00, A61P11/06, A61P9/00, A61P9/04